Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
The weight-loss-drug manufacturer failed to excite investors hoping for a turnaround.
Los artículos de esta sección se muestran en inglés.
Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
Trade News, 2026-09-21 resume el mercado: Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030 The weight-loss-drug manufacturer failed to excite investors hoping for a… Fuente primaria: original en MarketWatch (marketwatch.com).
Lee también
Novo shares slide as drugmaker lays out post-Wegovy growth strategy
Global stock markets bounce higher; government bond yields tumble as oil slides – business live
‘She says it’s just money’: My friend pays for everything. I should be grateful, but I can’t stand her anymore.
